PD56 - PD56: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III

Podium Presenter(s)

• AB

  Alfredo Bove
• GB

  Giorgio Bozzini, MD

  Humanitas Mater Domini
• 

  Oussama Darwish, MD

  University at Buffalo

  PDF Slides and Audio
• 

  Dean Elterman, MD, MSc, FRCSC

  University of Toronto

  PDF Slides and Audio
• 

  Vishnuvardhan Ganesan, MD

  UT Southwestern

  PDF Slides and Audio
• 

  Peter Gilling, MD

  University of Auckland, Bay of Plenty Clinical Campus, Tauranga

  PDF Slides
• 

  Yasser Hussein Mohamed Ismail, MD

  PDF Slides and Audio
• 

  Alison Levy, MD

  Lahey Hospital and Medical Center

  PDF Slides and Audio
• KR

  Kyle Rose, MD

  Mayo Clinic Arizona

  PDF Slides and Audio
• JS

  Jared Schober
• CT

  Chung-You Tsai
• 

  Charles Welliver, MD

  Albany Medical College

  PDF Slides and Audio

Presentations:

• 7:00 AM – 9:00 AM

  PD56-01: Prostate specific antigen kinetics predict incidental prostate cancer progression following holmium laser enucleation of the prostate
  Kyle M. Rose, MD
• 7:00 AM – 9:00 AM

  PD56-02: Use of HoLEP in Men on Active Surveillance for Low-Risk Prostate Cancer
  Jared Schober
• 7:00 AM – 9:00 AM

  PD56-03: National Surgical Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
  Charles Welliver, MD
• 7:00 AM – 9:00 AM

  PD56-04: Comparative efficacy of novel surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis
  Chung-You Tsai
• 7:00 AM – 9:00 AM

  PD56-05: Three-Year Outcomes after Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained
  Peter J. Gilling, MD – Urology BOP
• 7:00 AM – 9:00 AM

  PD56-06: Transfusion Rates After 800 Aquablation Procedures Using Various Hemostasis Methods
  Dean Sol Elterman, MD, MSc, FRCSC
• 7:00 AM – 9:00 AM

  PD56-07: vs MoLEP, first prospective randomized trial on 140 patients
  Yasser Hussein Mohamed Ismail, MD – UOC Urologia - ASST Bergamo Ovest
• 7:00 AM – 9:00 AM

  PD56-08: Thulium laser enucleation of the prostate versus open prostatectomy: A prospective cost analysis
  Giorgio Bozzini, MD
• 7:00 AM – 9:00 AM

  PD56-09: Combination Robotic Simple Prostatectomy and HoLEP for Morbidly Enlarged Prostates >400g
  Alison C. Levy, MD
• 7:00 AM – 9:00 AM

  PD56-10: Retrospective comparison of perioperative and 1-yr self-reported functional outcomes between Millin, Freyer and Madigan Robot assisted simple prostatectomy: single center series
  Alfredo Bove
• 7:00 AM – 9:00 AM

  PD56-11: Port robotic assisted simple prostatectomy is associated with decreased post-operative narcotic use.
  Vishnuvardhan Ganesan, MD – UT Southwestern Department of Urology
• 7:00 AM – 9:00 AM

  PD56-12: Fail To Rescue: Causes Of Mortality Post TURP
  Oussama Mustafa Darwish, MD